Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Bone marrow transplantation. - 56, 8 (2021) , 2042, ISSN: 1476-5365
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- Urheber
- DOI
-
10.1038/s41409-021-01366-y
- URN
-
urn:nbn:de:bsz:25-freidok-2198108
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2021
Ähnliche Objekte (12)
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Allogeneic stem cell transplantation in multiple myeloma
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Response to daratumumab-retreatment in patients with multiple myeloma
Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Allogeneic stem cell transplantation in multiple myeloma
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Response to daratumumab-retreatment in patients with multiple myeloma
Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis
Risk of disease recurrence and survival in patients with multiple myeloma: A German Study Group analysis using a conditional survival approach with long‐term follow‐up of 815 patients
Allogeneic stem cell transplantation in multiple myeloma
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia
Response to daratumumab-retreatment in patients with multiple myeloma
Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients
Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning
The impact of pulmonary function in patients undergoing autologous stem cell transplantation
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis